TCR2 THERAPEUTICS INC. Quarterly Entity Common Stock, Shares Outstanding from Q1 2019 to Q1 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Tcr2 Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2019 to Q1 2023.
  • Tcr2 Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending March 5, 2023 was 39.2M shares, a 1.81% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 39.2M +698K +1.81% Mar 5, 2023 10-K 2023-03-23
Q3 2022 38.7M +437K +1.14% Nov 1, 2022 10-Q 2022-11-08
Q2 2022 38.6M +424K +1.11% Aug 1, 2022 10-Q 2022-08-08
Q1 2022 38.5M +409K +1.07% Mar 18, 2022 10-K 2022-03-22
Q3 2021 38.2M +4.8M +14.4% Nov 2, 2021 10-Q 2021-11-10
Q2 2021 38.2M +4.84M +14.5% Aug 2, 2021 10-Q 2021-08-05
Q1 2021 38.1M +14.1M +58.4% Mar 1, 2021 10-K 2021-03-16
Q3 2020 33.4M +9.39M +39.1% Nov 3, 2020 10-Q 2020-11-12
Q2 2020 33.3M +9.38M +39.1% Aug 3, 2020 10-Q 2020-08-12
Q1 2020 24.1M +136K +0.57% Mar 21, 2020 10-K 2020-03-30
Q3 2019 24M Oct 31, 2019 10-Q 2019-11-12
Q2 2019 24M Jul 30, 2019 10-Q 2019-08-09
Q1 2019 23.9M May 6, 2019 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.